Showing results (301-310 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|July 30, 1999
PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinomaR S Witte, L M Ryan, A J Schutt, et al.Investigational New Drugs|July 30, 1999
A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumorsJ D Berlin, D B Alberti, R Z Arzoomanian, et al.Investigational New Drugs|July 30, 1999
Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124)F J Meyers, D Lew, P N Lara, et al.Investigational New Drugs|July 30, 1999
A phase II trial of irinotecan in hormone-refractory prostate cancerD M Reese, S Tchekmedyian, Y Chapman, et al.Investigational New Drugs|April 9, 2001
A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignanciesC D Blanke, M Stipanov, J Morrow, et al.Investigational New Drugs|April 9, 2001
Factors affecting the pharmacokinetics of CPT-11: the body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11T Miya, T Goya, H Fujii, et al.Investigational New Drugs|April 9, 2001
A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group StudyS C Plaxe, J A Blessing, J A Lucci, et al.Investigational New Drugs|November 18, 2000
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical developmentJ L GremInvestigational New Drugs|June 17, 2000
Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell linesM Taron, C Plasencia, A Abad, et al.Pageof 372